Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Soligenix Inc (SNGX)

Soligenix Inc (SNGX)
2.06 -0.01 (-0.48%) 09:41 ET [NASDAQ]
2.02 x 1 2.10 x 15
Realtime by (Cboe BZX)
2.02 x 1 2.10 x 15
Realtime - - (-) -
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
2.06
Day High
2.06
Open 2.06
Previous Close 2.07 2.07
Volume 366 366
Avg Vol 205,691 205,691
Stochastic %K 67.70% 67.70%
Weighted Alpha -81.66 -81.66
5-Day Change +0.10 (+4.85%) +0.10 (+4.85%)
52-Week Range 1.68 - 14.83 1.68 - 14.83
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,195
  • Shares Outstanding, K 2,510
  • Annual Sales, $ 120 K
  • Annual Income, $ -8,270 K
  • EBIT $ -9 M
  • EBITDA $ -9 M
  • 60-Month Beta 1.85
  • Price/Sales 44.29
  • Price/Cash Flow N/A
  • Price/Book 1.28

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.68 +22.32%
on 04/04/25
Period Open: 2.39
2.41 -14.73%
on 03/26/25
-0.34 (-14.02%)
since 03/21/25
3-Month
1.68 +22.32%
on 04/04/25
Period Open: 2.46
2.63 -21.86%
on 01/24/25
-0.40 (-16.46%)
since 01/22/25
52-Week
1.68 +22.32%
on 04/04/25
Period Open: 6.49
14.83 -86.14%
on 07/09/24
-4.44 (-68.35%)
since 04/22/24

Most Recent Stories

More News
Soligenix (NASDAQ: SNGX) Advances CiVax Amid Ongoing COVID-19 Threat

Despite the passage of time since the pandemic, COVID-19 continues to pose a significant global health threat. Recent data from the World Health Organization (“WHO”) indicates that during the 28-day...

SNGX : 2.06 (-0.72%)
BMWYY : 29.2000 (+4.58%)
Soligenix (NASDAQ: SNGX) Announces Positive Data, Continued Advancement of HyBryte(TM)

Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company today announced...

SNGX : 2.06 (-0.72%)
Soligenix (NASDAQ: SNGX) Spotlighted in Zacks Small-Cap Research Report, Earns $35 Valuation

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company specializing in developing and commercializing products to treat rare diseases, has recently been the focus of a comprehensive analysis...

SNGX : 2.06 (-0.72%)
BMWYY : 29.2000 (+4.58%)
Soligenix (NASDAQ: SNGX) Advances Phase 3 Replication Study for Early-Stage Cutaneous T-Cell Lymphoma Treatment

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company specializing in the development and commercialization of treatments for rare diseases and unmet medical needs, is making significant strides...

SNGX : 2.06 (-0.72%)
BMWYY : 29.2000 (+4.58%)
Zacks Maintains $35.00 Price Per Share Valuation for Soligenix (NASDAQ: SNGX) Amid Promising Vaccine and CTCL Therapy Progress

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a recent Zacks Small-Cap Research report that presented a favorable analysis, emphasizing the...

SNGX : 2.06 (-0.72%)
Soligenix (NASDAQ: SNGX) Announces Key Milestones and 2024 Financial Results

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today announced its recent...

SNGX : 2.06 (-0.72%)
Why Soligenix (NASDAQ: SNGX) Is ‘One to Watch’

Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. “Operating through two key segments,...

SNGX : 2.06 (-0.72%)
Soligenix (NASDAQ: SNGX) Is ‘One to Watch’

Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for rare diseases with high unmet medical needs. Operating through two key segments,...

SNGX : 2.06 (-0.72%)
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Investor Summit Group, committed to advancing the MicroCap and SmallCap investment community, announces that the November 21, 2024 Winter Investor Summit...

IMRN : 1.7768 (+6.25%)
ULY : 4.59 (+1.10%)
IMUX : 0.9852 (-0.39%)
NMTC : 0.5499 (-3.02%)
SNGX : 2.06 (-0.72%)
TMG.VN : 0.115 (unch)
BLGO : 0.2392 (+0.25%)
FET : 14.93 (+1.56%)
ACFN : 14.4800 (+1.26%)
NRBO : 2.36 (+0.43%)
TGCB : 0.0340 (+5.26%)
SOTK : 3.75 (+1.63%)
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025

ATLANTIC CITY, NJ / ACCESSWIRE / November 27, 2024 / DealFlow Events is pleased to announce the initial lineup of companies participating in The Microcap Conference, set for January 28-30 in Atlantic City,...

THAR : 1.1300 (-1.74%)
ACXP : 0.3799 (+2.95%)
UBI.AX : 0.061 (unch)
GRF.VN : 0.470 (unch)
WISA : 1.2100 (-6.92%)
NNVC : 1.3335 (+2.58%)
ALCO : 28.75 (-0.28%)
MYPS : 1.2100 (-3.97%)
ABL : 8.38 (+3.97%)
PERF : 1.6000 (-0.62%)
PETV : 0.5000 (-3.83%)
ABEO : 5.13 (+4.27%)

Business Summary

Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases where, as well as developing several biodefense vaccines and therapeutics. The Company operates in two reportable...

See More

Key Turning Points

3rd Resistance Point 2.24
2nd Resistance Point 2.17
1st Resistance Point 2.12
Last Price 2.06
1st Support Level 2.00
2nd Support Level 1.92
3rd Support Level 1.87

See More

52-Week High 14.83
Fibonacci 61.8% 9.81
Fibonacci 50% 8.25
Fibonacci 38.2% 6.70
Last Price 2.06
52-Week Low 1.68

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro